Learner Objectives

By participating in this continuing education program, the attendee should be able to:

  • Describe the framework for IRB review
  • Identify 3 criteria an IRB must consider when determining if a study is approvable
  • Explain considerations that an IRB makes when evaluating risk/benefit ratio, minimization of risks and the composition of the informed consent document.

Faculty Disclosure 

The faculty has no commercial relationships with any entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients.


Robert Baevsky MD, FACEP
Chair Baystate IRB Board 2
Gerald Korona RPh
Vice Chair Baystate IRB Board 1 
Jennifer Pacheco MPH, CIM, CIP
Director Healthcare Research Compliance; Chief Research Compliance Officer
Peter DePergola II, PhD, MTS
Director Clinical Ethics, Baystate Health
IRB Member Baystate IRB Board 1
Marypat Toye RN , MS, ACRN, CCRP, CPXP
Vice Chair Baystate IRB Board 2 
Session date: 
10/17/2019 - 12:00pm to 1:00pm EDT
Chestnut 5
759 Chestnut St.
Springfield, MA 01199
United States

Please login or register to take this course.